{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/NTRA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T12:44:01.039Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":1265,"canonical_name":"Natera, Inc.","cik":"0001604821","uei":null,"lei":null,"duns":null,"ticker":"NTRA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":213,"clinical":5},"count":100,"timeline":[{"ts":"2026-10-09","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-10-09","url_slug":"/sec/cik-0001604821/4/0001646382-26-000022","accession_number":"0001646382-26-000022","importance":30},{"ts":"2026-10-07","kind":"sec.insider.6000","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":6000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-10-02","url_slug":"/sec/cik-0001604821/4/0001711968-26-000023","accession_number":"0001711968-26-000023","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-10-02","url_slug":"/sec/cik-0001604821/4/0002010019-26-000030","accession_number":"0002010019-26-000030","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-10-01","url_slug":"/sec/cik-0001604821/144/0001950047-26-009911","accession_number":"0001950047-26-009911","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-10-01","url_slug":"/sec/cik-0001604821/144/0001950047-26-009948","accession_number":"0001950047-26-009948","importance":30},{"ts":"2026-10-01","kind":"sec.insider.1846","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":1846,"price_per_share":415.0691,"usd_value":766218,"security_title":"Common Stock","importance":15.7662175586},{"ts":"2026-10-01","kind":"sec.insider.1273","reporter":"Chapman Steven Leonard","title":"CEO AND PRESIDENT","shares":1273,"price_per_share":413.31,"usd_value":526144,"security_title":"Common Stock","importance":15.52614363},{"ts":"2026-10-01","kind":"sec.insider.954","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":954,"price_per_share":413.1066,"usd_value":394104,"security_title":"Common Stock","importance":15.3941036964},{"ts":"2026-10-01","kind":"sec.insider.200","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":200,"price_per_share":411.62,"usd_value":82324,"security_title":"Common Stock","importance":15.082324},{"ts":"2026-09-25","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-09-25","url_slug":"/sec/cik-0001604821/4/0001646649-26-000033","accession_number":"0001646649-26-000033","importance":30},{"ts":"2026-09-23","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-09-23","url_slug":"/sec/cik-0001604821/144/0001949846-26-000594","accession_number":"0001949846-26-000594","importance":30},{"ts":"2026-09-23","kind":"sec.insider.2846","reporter":"Sheena Jonathan","title":null,"shares":2846,"price_per_share":387.7351,"usd_value":1103494,"security_title":"Common Stock","importance":16.1034940946},{"ts":"2026-09-23","kind":"sec.insider.2734","reporter":"Sheena Jonathan","title":null,"shares":2734,"price_per_share":387.6545,"usd_value":1059847,"security_title":"Common Stock","importance":16.059847403},{"ts":"2026-09-23","kind":"sec.insider.2320","reporter":"Sheena Jonathan","title":null,"shares":2320,"price_per_share":389.685,"usd_value":904069,"security_title":"Common Stock","importance":15.9040692},{"ts":"2026-09-23","kind":"sec.insider.2300","reporter":"Sheena Jonathan","title":null,"shares":2300,"price_per_share":386.6396,"usd_value":889271,"security_title":"Common Stock","importance":15.88927108},{"ts":"2026-09-23","kind":"sec.insider.2175","reporter":"Sheena Jonathan","title":null,"shares":2175,"price_per_share":386.7144,"usd_value":841104,"security_title":"Common Stock","importance":15.84110382},{"ts":"2026-09-23","kind":"sec.insider.1935","reporter":"Sheena Jonathan","title":null,"shares":1935,"price_per_share":389.7108,"usd_value":754090,"security_title":"Common Stock","importance":15.754090398},{"ts":"2026-09-23","kind":"sec.insider.1341","reporter":"Sheena Jonathan","title":null,"shares":1341,"price_per_share":388.7637,"usd_value":521332,"security_title":"Common Stock","importance":15.5213321217},{"ts":"2026-09-23","kind":"sec.insider.1293","reporter":"Sheena Jonathan","title":null,"shares":1293,"price_per_share":388.7071,"usd_value":502598,"security_title":"Common Stock","importance":15.5025982803},{"ts":"2026-09-23","kind":"sec.insider.400","reporter":"Sheena Jonathan","title":null,"shares":400,"price_per_share":385.1025,"usd_value":154041,"security_title":"Common Stock","importance":15.154041},{"ts":"2026-09-23","kind":"sec.insider.390","reporter":"Sheena Jonathan","title":null,"shares":390,"price_per_share":385.2906,"usd_value":150263,"security_title":"Common Stock","importance":15.150263334},{"ts":"2026-09-23","kind":"sec.insider.220","reporter":"Sheena Jonathan","title":null,"shares":220,"price_per_share":390.525,"usd_value":85916,"security_title":"Common Stock","importance":15.0859155},{"ts":"2026-09-23","kind":"sec.insider.110","reporter":"Sheena Jonathan","title":null,"shares":110,"price_per_share":390.42,"usd_value":42946,"security_title":"Common Stock","importance":15.0429462},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-09-18","url_slug":"/sec/cik-0001604821/4/0002010019-26-000029","accession_number":"0002010019-26-000029","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-09-17","url_slug":"/sec/cik-0001604821/4/0001646649-26-000032","accession_number":"0001646649-26-000032","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-09-16","url_slug":"/sec/cik-0001604821/4/0001646382-26-000021","accession_number":"0001646382-26-000021","importance":30},{"ts":"2026-09-16","kind":"sec.insider.1400","reporter":"Sheena Jonathan","title":null,"shares":1400,"price_per_share":353.83,"usd_value":495362,"security_title":"Common Stock","importance":15.495362},{"ts":"2026-09-16","kind":"sec.insider.800","reporter":"Sheena Jonathan","title":null,"shares":800,"price_per_share":355.9475,"usd_value":284758,"security_title":"Common Stock","importance":15.284758},{"ts":"2026-09-16","kind":"sec.insider.450","reporter":"Sheena Jonathan","title":null,"shares":450,"price_per_share":354.9133,"usd_value":159711,"security_title":"Common Stock","importance":15.159710985},{"ts":"2026-09-16","kind":"sec.insider.200","reporter":"Sheena Jonathan","title":null,"shares":200,"price_per_share":356.8664,"usd_value":71373,"security_title":"Common Stock","importance":15.07137328},{"ts":"2026-09-16","kind":"sec.insider.200","reporter":"Sheena Jonathan","title":null,"shares":200,"price_per_share":348.025,"usd_value":69605,"security_title":"Common Stock","importance":15.069605},{"ts":"2026-09-16","kind":"sec.insider.100","reporter":"Sheena Jonathan","title":null,"shares":100,"price_per_share":349.045,"usd_value":34905,"security_title":"Common Stock","importance":15.0349045},{"ts":"2026-09-16","kind":"sec.insider.945","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":945,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-09-15","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-09-15","url_slug":"/sec/cik-0001604821/144/0001950047-26-009533","accession_number":"0001950047-26-009533","importance":30},{"ts":"2026-09-15","kind":"sec.insider.6000","reporter":"Sheena Jonathan","title":null,"shares":6000,"price_per_share":350.0718,"usd_value":2100431,"security_title":"Common Stock","importance":17.100430799999998},{"ts":"2026-09-11","kind":"sec.form144","reporter":"MATTHEW RABINOWITZ","title":"Director, Officer","shares":200000,"usd_value":65228000,"security_title":"Common","approx_sale_date":"2026-09-11","accession_number":"0001950047-26-009345","importance":53.0456},{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":17933,"price_per_share":327.9724,"usd_value":5881529,"security_title":"Common Stock","importance":40.8815290492},{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":15764,"price_per_share":328.9502,"usd_value":5185571,"security_title":"Common Stock","importance":40.1855709528},{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":10556,"price_per_share":327.1442,"usd_value":3453334,"security_title":"Common Stock","importance":38.4533341752},{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":3647,"price_per_share":326.1077,"usd_value":1189315,"security_title":"Common Stock","importance":36.1893147819},{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":1300,"price_per_share":329.6247,"usd_value":428512,"security_title":"Common Stock","importance":35.42851211},{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":800,"price_per_share":325.0075,"usd_value":260006,"security_title":"Common Stock","importance":35.260006},{"ts":"2026-09-11","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-09-11","url_slug":"/sec/cik-0001604821/144/0001950047-26-009345","accession_number":"0001950047-26-009345","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-09-11","url_slug":"/sec/cik-0001604821/4/0001646382-26-000019","accession_number":"0001646382-26-000019","importance":30},{"ts":"2026-09-11","kind":"sec.insider.17933","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":17933,"price_per_share":327.9724,"usd_value":5881529,"security_title":"Common Stock","importance":20.8815290492},{"ts":"2026-09-11","kind":"sec.insider.15764","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":15764,"price_per_share":328.9502,"usd_value":5185571,"security_title":"Common Stock","importance":20.1855709528},{"ts":"2026-09-11","kind":"sec.insider.10556","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":10556,"price_per_share":327.1442,"usd_value":3453334,"security_title":"Common Stock","importance":18.4533341752},{"ts":"2026-09-11","kind":"sec.insider.3647","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":3647,"price_per_share":326.1077,"usd_value":1189315,"security_title":"Common Stock","importance":16.1893147819},{"ts":"2026-09-11","kind":"sec.insider.1300","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":1300,"price_per_share":329.6247,"usd_value":428512,"security_title":"Common Stock","importance":15.42851211},{"ts":"2026-09-11","kind":"sec.insider.800","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":800,"price_per_share":325.0075,"usd_value":260006,"security_title":"Common Stock","importance":15.260006},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-09-03","url_slug":"/sec/cik-0001604821/4/0001711968-26-000022","accession_number":"0001711968-26-000022","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-09-03","url_slug":"/sec/cik-0001604821/4/0002010019-26-000028","accession_number":"0002010019-26-000028","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-09-02","url_slug":"/sec/cik-0001604821/144/0002010019-26-000027","accession_number":"0002010019-26-000027","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-09-01","url_slug":"/sec/cik-0001604821/144/0001950047-26-008885","accession_number":"0001950047-26-008885","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-09-01","url_slug":"/sec/cik-0001604821/144/0001950047-26-008891","accession_number":"0001950047-26-008891","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-28","url_slug":"/sec/cik-0001604821/4/0002010135-26-000020","accession_number":"0002010135-26-000020","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-14","url_slug":"/sec/cik-0001604821/4/0001646649-26-000030","accession_number":"0001646649-26-000030","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Natera, Inc. — 2026-08-14","url_slug":"/sec/cik-0001604821/schedule-13g-a/0000080255-26-000548","accession_number":"0000080255-26-000548","importance":30},{"ts":"2026-08-13","kind":"clinical.trial","reporter":"Natera, Inc.","title":"Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)","security_title":null,"status":"RECRUITING","accession_number":"NCT07763197","excerpt":"[\"Non-Muscle Invasive Bladder Cancer\",\"NMIBC\",\"High-risk Non-Muscle Invasive Bladder Cancer\"]","importance":25},{"ts":"2026-08-07","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Natera, Inc. — 2026-08-07","url_slug":"/sec/cik-0001604821/10-q/0001628280-26-054525","accession_number":"0001628280-26-054525","importance":45},{"ts":"2026-08-07","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-08-07","url_slug":"/sec/cik-0001604821/144/0001949846-26-000478","accession_number":"0001949846-26-000478","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-08-07","url_slug":"/sec/cik-0001604821/144/0001950047-26-007836","accession_number":"0001950047-26-007836","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-07","url_slug":"/sec/cik-0001604821/4/0001646382-26-000018","accession_number":"0001646382-26-000018","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-07","url_slug":"/sec/cik-0001604821/4/0001646649-26-000029","accession_number":"0001646649-26-000029","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"S-8","title":"S-8 — Natera, Inc. — 2026-08-07","url_slug":"/sec/cik-0001604821/s-8/0001604821-26-000021","accession_number":"0001604821-26-000021","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Natera, Inc. — 2026-08-06","url_slug":"/sec/cik-0001604821/8-k/0001604821-26-000015","accession_number":"0001604821-26-000015","importance":35},{"ts":"2026-08-06","kind":"clinical.trial","reporter":"Natera, Inc.","title":"Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)","security_title":null,"status":"RECRUITING","accession_number":"NCT07750886","excerpt":"[\"Non-Hodgkin Lymphoma\",\"T-Cell Lymphoma\",\"Diffuse Large B-Cell Lymphoma\",\"High-Grade B-Cell Lymphoma\",\"Primary Mediastinal B-Cell Lymphoma\",\"Peripheral T-Cell Lymphoma\",\"Transformed Follicular Lymphoma\",\"Follicular Lymphoma Grade 3B\",\"Follicular Lymphoma\",\"Anaplastic Large Cell Lymphoma\"]","importance":25},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-05","url_slug":"/sec/cik-0001604821/4/0001646382-26-000017","accession_number":"0001646382-26-000017","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-05","url_slug":"/sec/cik-0001604821/4/0001646649-26-000028","accession_number":"0001646649-26-000028","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-05","url_slug":"/sec/cik-0001604821/4/0001697362-26-000017","accession_number":"0001697362-26-000017","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-05","url_slug":"/sec/cik-0001604821/4/0001711968-26-000021","accession_number":"0001711968-26-000021","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-05","url_slug":"/sec/cik-0001604821/4/0001857843-26-000024","accession_number":"0001857843-26-000024","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-05","url_slug":"/sec/cik-0001604821/4/0002010019-26-000024","accession_number":"0002010019-26-000024","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Natera, Inc. — 2026-08-05","url_slug":"/sec/cik-0001604821/4/0002010135-26-000019","accession_number":"0002010135-26-000019","importance":30},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"Brophy Michael Burkes","title":"CHIEF FINANCIAL OFFICER","shares":478,"price_per_share":274.22,"usd_value":131077,"security_title":"Common Stock","importance":35.13107716},{"ts":"2026-08-04","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-08-04","url_slug":"/sec/cik-0001604821/144/0001950047-26-007649","accession_number":"0001950047-26-007649","importance":30},{"ts":"2026-08-04","kind":"clinical.trial","reporter":"Natera, Inc.","title":"A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.","security_title":"NA","status":"NOT_YET_RECRUITING","accession_number":"NCT07689812","excerpt":"[\"NSCLC (Advanced Non-small Cell Lung Cancer)\",\"NSCLC (Non-small Cell Lung Cancer)\",\"NSCLC (Non-small Cell Lung Carcinoma)\",\"NSCLC\",\"Melanoma (Skin Cancer)\",\"Melanoma (Skin) Stage IV\",\"CRC\",\"MSI High Colorectal Cancer\",\"DMMR Colorectal Cancer\",\"RCC, Renal Cell Cancer\",\"RCC\",\"Solid Tumors\",\"Metastatic Solid Tumors\",\"Advanced Solid Tumors\",\"Advanced Solid Tumors Cancer\"]","importance":25},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":1233,"price_per_share":267.7869,"usd_value":330181,"security_title":"Common Stock","importance":35.3301812477},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Chapman Steven Leonard","title":"CEO AND PRESIDENT","shares":1182,"price_per_share":267.9893,"usd_value":316763,"security_title":"Common Stock","importance":35.3167633526},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":947,"price_per_share":263.9415,"usd_value":249953,"security_title":"Common Stock","importance":35.2499526005},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Rabinowitz Matthew","title":"EXECUTIVE CHAIRMAN","shares":731,"price_per_share":267.9893,"usd_value":195900,"security_title":"Common Stock","importance":35.1959001783},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Chapman Steven Leonard","title":"CEO AND PRESIDENT","shares":676,"price_per_share":263.8622,"usd_value":178371,"security_title":"Common Stock","importance":35.1783708472},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Chapman Steven Leonard","title":"CEO AND PRESIDENT","shares":612,"price_per_share":268.2187,"usd_value":164150,"security_title":"Common Stock","importance":35.1641498444},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":410,"price_per_share":267.9893,"usd_value":109876,"security_title":"Common Stock","importance":35.109875613},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"RABINOWITZ DANIEL","title":"SEC. AND CHIEF LEGAL OFFICER","shares":334,"price_per_share":267.9893,"usd_value":89508,"security_title":"Common Stock","importance":35.0895084262},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Brophy Michael Burkes","title":"CHIEF FINANCIAL OFFICER","shares":317,"price_per_share":267.9893,"usd_value":84953,"security_title":"Common Stock","importance":35.0849526081},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Fesko John","title":"PRESIDENT, CHIEF BUS. OFFICER","shares":295,"price_per_share":267.9893,"usd_value":79057,"security_title":"Common Stock","importance":35.0790568435},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Chapman Steven Leonard","title":"CEO AND PRESIDENT","shares":296,"price_per_share":267.0838,"usd_value":79057,"security_title":"Common Stock","importance":35.0790568048},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":300,"price_per_share":259.98,"usd_value":77994,"security_title":"Common Stock","importance":35.077994},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":200,"price_per_share":261.4875,"usd_value":52298,"security_title":"Common Stock","importance":35.0522975},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":192,"price_per_share":265.275,"usd_value":50933,"security_title":"Common Stock","importance":35.0509328},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Chapman Steven Leonard","title":"CEO AND PRESIDENT","shares":160,"price_per_share":259.98,"usd_value":41597,"security_title":"Common Stock","importance":35.0415968},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Moshkevich Solomon","title":"PRESIDENT, CLINICALDIAGNOSTICS","shares":128,"price_per_share":268.6964,"usd_value":34393,"security_title":"Common Stock","importance":35.0343931392},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Sheena Jonathan","title":"","shares":109,"price_per_share":267.9893,"usd_value":29211,"security_title":"Common Stock","importance":35.0292108337},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Chapman Steven Leonard","title":"CEO AND PRESIDENT","shares":80,"price_per_share":265.27,"usd_value":21222,"security_title":"Common Stock","importance":35.0212216},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Chapman Steven Leonard","title":"CEO AND PRESIDENT","shares":70,"price_per_share":261.025,"usd_value":18272,"security_title":"Common Stock","importance":35.01827175},{"ts":"2026-08-03","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-08-03","url_slug":"/sec/cik-0001604821/144/0001646382-26-000016","accession_number":"0001646382-26-000016","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-08-03","url_slug":"/sec/cik-0001604821/144/0001646649-26-000027","accession_number":"0001646649-26-000027","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"144","title":"144 — Natera, Inc. — 2026-08-03","url_slug":"/sec/cik-0001604821/144/0001697362-26-000016","accession_number":"0001697362-26-000016","importance":30}]}